ALSUntangled found little objective evidence to support NuTech Mediworld’s stem cell treatment
Original source
NuTech Mediworld (opens in a new tab)An ALSUntangled review found little objective information about the safety or effectiveness of NuTech Mediworld’s treatment for amyotrophic lateral sclerosis (ALS). The review described embryonic cell treatment, limited clinical documentation and unvalidated outcome reports. In one patient with available measurements, disease progression may have worsened after treatment.
Why this matters
This concerns people considering an expensive, unproven treatment at a stem cell clinic in New Delhi. The review does not show that the treatment benefits people with ALS and does not support changing treatment based on these reports.
Limitations and context
This was an expert review based on available records, clinic contacts, published literature searches and information from two patients, not a clinical trial. The clinic did not respond to the reviewers, and no detailed treatment protocol or reliable safety and efficacy data were available. The review was published in 2011, so it does not establish the clinic’s current practices.